Significant heightened methylation levels of < em > RUNX3 < /em > gene promoter in patients with systemic lupus erythematosus

CONCLUSION: The findings of this study emphasize the potential use of RUNX3 methylation levels in PBMCs of SLE patients as biomarkers for diagnosing the disease, predicting renal damage, and assessing disease activity.PMID:38511579 | DOI:10.1177/09612033241241850

Source: Lupus - March 21, 2024 Category: Rheumatology Authors: Naeim Ehtesham Samira Alesaeidi Dorita Mohammad Zadeh Mozhdeh Saghaei Maryam Fakhri Zahra Bayati Emran Esmaeilzadeh Meysam Mosallaei Source Type: research